Vicapsys Life Sciences (VICP) Stock Statistics & Valuation Metrics
Total Valuation
Vicapsys Life Sciences has a market cap or net worth of $14.57M. The enterprise value is $47.84T.
- Market Cap
- $14.57M
- Enterprise Value
- $47.84T
Share Statistics
Vicapsys Life Sciences has 32,371,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 32,371,300
- Owned by Insiders
- ―
- Owned by Institutions
- 0.23%
Financial Efficiency
Vicapsys Life Sciences’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 22.05%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- -261.62
- Return on Invested Capital (ROIC)
- 22.05%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 0
- Profits Per Employee
- -344.94K
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Vicapsys Life Sciences is -23.08. Vicapsys Life Sciences’s PEG ratio is -0.54.
- PE Ratio
- -23.08
- PS Ratio
- 0.00
- PB Ratio
- -4.45
- Price to FCF
- -678.80
- Price to Operating Cash Flow
- -741.61
- PEG Ratio
- -0.54
Income Statement
In the last 12 months, Vicapsys Life Sciences had revenue of 0 and earned -689.89K in profits. Earnings per share was -0.02.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -651.80K
- Pretax Income
- -689.89K
- Net Income
- -689.89K
- EBITDA
- -651.80K
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -5,094 and capital expenditures 5, giving a free cash flow of -5,090 billion.
- Operating Cash Flow
- -5,094
- Free Cash Flow
- -5,090
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Vicapsys Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.15%
- Earnings Yield
- -4.33%
Stock Price Statistics
- Beta
- 1208328.60
- 52-Week Price Change
- -70.00%
- 50-Day Moving Average
- 0.76
- 200-Day Moving Average
- 1.28
- Relative Strength Index (RSI)
- 44.07
- Average Volume (3m)
- 4,103
Financial Position
Vicapsys Life Sciences as a current ratio of 0.00, with Debt / Equity ratio of -17.44%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.95
- Interest Coverage Ratio
- -17.11
Taxes
In the past 12 months, Vicapsys Life Sciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Vicapsys Life Sciences EV to EBITDA ratio is -23.30, with an EV/FCF ratio of -707.77.
- EV to Sales
- 0.00
- EV to EBITDA
- -23.30
- EV to Free Cash Flow
- -707.77
- EV to Operating Cash Flow
- -707.67
Balance Sheet
Vicapsys Life Sciences has $132.54K in cash and marketable securities with $624.35K in debt, giving a net cash position of -$491.80K billion.
- Cash & Marketable Securities
- $132.54K
- Total Debt
- $624.35K
- Net Cash
- -$491.80K
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- -$0.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Vicapsys Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―